This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
To tackle this problem, researchers compared Veterans Affairs data on 2 million T2D patients (2017-2023) taking either GLP-1s , DPP4is, SGLT2is, or usual care antihyperglycemics over a 3.68 Starting with the good news, GLP-1s lowered risks for 42 health outcomes while increasing risks for 19 outcomes. year follow-up.
Stroke, Ahead of Print. BACKGROUND:Recently, various polygenic risk score (PRS)based methods were developed to improve stroke prediction. However, current PRSs (including cross-ancestry PRS) poorly predict recurrent stroke. In particular, it predicted an increased risk of recurrence among stroke patients without hypertension.
Stroke, Ahead of Print. BACKGROUND:Therapeutic-induced hypertension treatment (iHTN) is helpful for alleviating early neurological deterioration (END) in acute small vessel occlusive stroke. The mean age was 65.1 (±12.0) years, and 61.0% The efficacy of iHTN may be limited to induction within the first 3 hours of END.
7-9, and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health. 7-9, and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health. The meeting will be held in Phoenix, Feb. The meeting will be held in Phoenix, Feb.
Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5%
Awareness of symptoms is vital for early recognition and prompt treatment, which can significantly improve health outcomes. Conclusion:There is significant heterogeneity in MI and stroke symptom awareness among Asian American adults. female, mean age 44.6 years [SD: 16.5 Ethnic distribution was 22.0% Asian Indian, 22.5% Chinese, 20.8%
In our study population of 1000 thrombectomy‐eligible patients (513 women; median age, 77 years [interquartile range, 67–84]), IVT emerged as a predictor of favorable functional outcome (modified Rankin Scale score, 0–2) independent of modified mTICI score (adjusted odds ratio, 0.49 [95% CI, 0.32–0.75];P=0.001). 0.75];P=0.001).
Background Redo sternotomy aortic root surgery is technically demanding, and the evidence on outcomes is mostly from retrospective, small sample, single-centre studies. We report the trend, early clinical results and outcome predictors of redo aortic root replacement over 20 years in the United Kingdom.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionOptimal triage strategies for patients suspected of acute ischemic stroke due to large vessel occlusion remains debated. Outcomes were compared for EVT hospitalizations with direct vs transferred presentation at discharge.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP58-ATMP58, February 1, 2024. Objectives:To determine the relationship between patient-reported outcome measures (PROMs) and volumetric biomarkers assessed on clinical imaging in acute ischemic stroke (AIS).Background:AIS Background:AIS is a leading cause of long-term disability.
This study sought to analyse temporal trends in patient demographics, procedural characteristics, and clinical outcomes at an Irish tertiary referral centre. Patient and procedural characteristics and clinical outcomes were compared across groups. Patient and procedural characteristics and clinical outcomes were compared across groups.
Stroke, Volume 56, Issue Suppl_1 , Page AWP246-AWP246, February 1, 2025. Introduction:Acute ischemic stroke (AIS) arising from Medium vessel occlusions (MeVO) poses substantial challenges in treatment and management. Cardioembolic stroke etiology was associated with a higher likelihood of excellent recanalization (1.67; 95% CI, 1.07-2.59;
Stroke, Volume 56, Issue Suppl_1 , Page ATP87-ATP87, February 1, 2025. Background:Early prediction of functional outcome after rtPA helps clinicians in prognostic conversations with stroke patients and their families. modified Rankin Scale (mRS) at one month, classified into good (mRS 2) and poor (mRS 5) outcomes was noted.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP5-AWMP5, February 1, 2024. In those who underwent thrombectomy (n=812) the association of IVT and favorable functional outcome was reproduced (adjusted OR 0.49; 95% CI [0.31;0.74]; p=0.001) and was further confirmed on propensity score analysis where IVT led to a 0.35-point
Stroke, Volume 56, Issue Suppl_1 , Page ADP40-ADP40, February 1, 2025. Introduction:Challenging anatomy and tortuous vessels have been associated with poor outcomes in endovasculat treatment (EVT) of stroke.
Stroke, Volume 55, Issue Suppl_1 , Page ATP97-ATP97, February 1, 2024. Obtaining delayed functional outcomes such as the modified Ranking score (mRS) after stroke is challenging in clinical practice, often resulting in missing data. Other scores were compared as secondary outcomes. ischemic stroke 84%, 16% TIA).
Stroke, Volume 56, Issue Suppl_1 , Page ADP42-ADP42, February 1, 2025. Introduction:The transitional period from hospital discharge to the community for stroke survivors is a vulnerable time as patients navigate healthcare systems with their new impairments. The control group included patients not enrolled in the program.
Patients with versus without PCI within 2 years were propensity matched to examine major adverse cardiovascular events (MACE), defined as a 1year composite of mortality, revascularization, and rehospitalization for myocardial infarction or stroke. Among 334 828 patients undergoing surgery, 2297 (0.68%) had PCI within 2 years.
High-quality, contemporary, multicenter data regarding clinical outcomes after PCI is scarce and poses a barrier to clinical decision-making for surgically ineligible patients. CONCLUSIONS:Ineligibility for surgical revascularization was associated with increased risk of long-term mortality after PCI.
Stroke, Volume 55, Issue Suppl_1 , Page A93-A93, February 1, 2024. One hospital had been an EPH throughout the study period (Group A: EPH 0), three transitioned to EPHs in November 2017 (Group B: EPH 1, EPH 2, EPH 3), and six were non-EPHs (Group C). were given tPA, 22% had LVO, and 9.5% underwent mechanical thrombectomy.
Background:Atrial fibrillation (AF) during pregnancy and puerperium is devastating for the mother and her family, yet data regarding incidence and outcomes are very limited.Objective:We aimed to investigate the incidence and outcomes of AF during pregnancy and puerperium in a large database. per 10,000 in 2017 (Ptrend< 0001).
Stroke, Volume 55, Issue Suppl_1 , Page AWMP85-AWMP85, February 1, 2024. Background:Endovascular thrombectomy (EVT) is the standard of care for patients with large vessel occlusion stroke with salvageable penumbra. 1) In our comprehensive stroke center we transitioned from first-line conscious sedation (CS) to GA in q4 2017.Methods:Retrospective
Stroke, Volume 55, Issue Suppl_1 , Page ATP82-ATP82, February 1, 2024. Introduction:The incidence of Large Vessel Occlusion-Acute Ischemic Stroke (LVO-AIS) continues to increase in young adults. 31 patients (18%) had stroke etiology as Large Artery Atherosclerosis (per TOAST criteria). underwent mechanical thrombectomy (MT).
Stroke, Volume 56, Issue Suppl_1 , Page AWP187-AWP187, February 1, 2025. Radial access can be an effective bailout strategy, but intraprocedural delays may negatively impact outcomes. Radial access can be an effective bailout strategy, but intraprocedural delays may negatively impact outcomes. Patients treated in 2023 (n=177, 3.4%
BackgroundSecondary prevention of ischemic stroke (IS) requires adequate diagnostic evaluation to identify the likely etiologic subtype. We compared the documentation rates and presence of risk factors, diagnostic testing, achievement/quality measures, and outcomes between patients with and without reported IS subtype.
These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer. They note a substantial increase in the frequency of these surgeries, emphasizing the importance of understanding outcomes.
Stroke, Volume 56, Issue Suppl_1 , Page A129-A129, February 1, 2025. Background:The most common cause of arterial ischemic stroke (AIS) in previously healthy children, focal cerebral arteriopathy (FCA) can progress rapidly over days with worsening brain injury. Study neuroradiologist (M.W.) and pediatric vascular neurologist (H.J.F.)
Stroke, Volume 55, Issue Suppl_1 , Page ATP195-ATP195, February 1, 2024. However, clinical outcomes remain similar. This study compares post-thrombectomy outcomes in both groups, matched by initial NIHSS scores.Method:From October 2017 to March 2023, we studied LVO cases undergoing thrombectomy for acute ischemic stroke.
Stroke, Volume 56, Issue Suppl_1 , Page AWP83-AWP83, February 1, 2025. Background:Stroke centers across the country followadhere to established best practice timeframes for stroke care delivery, such as door-to-doctor, door-to-CT, and door-to-needle times. 45 mins), on-scene-to-evaluation time improved by 48% (1.54
Stroke, Volume 55, Issue Suppl_1 , Page A13-A13, February 1, 2024. Background:Patients with acute ischemic stroke harboring a large vessel occlusion (LVO) admitted to non endovascular-capable centers often require inter-hospital transfer for thrombectomy.
Stroke, Volume 56, Issue Suppl_1 , Page A57-A57, February 1, 2025. Background:Acute ischemic stroke is a leading cause of death and disability in the U.S. Patients with an initial Alberta Stroke Program Early CT Score (ASPECTS)>6 were compared to those with ASPECTS < 6.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionDue to the relative rarity of unruptured intracranial aneurysms (UIA) in the pediatric population, evidence regarding treatment modalities and clinical outcomes remains limited.
Stroke, Volume 55, Issue Suppl_1 , Page AWP282-AWP282, February 1, 2024. Background:While blood pressure variability (BPV) is associated with poor cardiovascular outcomes, the relationship between BPV obtained in a very short interval and stroke is unknown. Up to 5% (487 patients) had a history of stroke.
Stroke, Volume 55, Issue Suppl_1 , Page ATP150-ATP150, February 1, 2024. Introduction:Ischemic stroke is a leading cause of death and disability in the US, with 20-40% of cases, classified as cryptogenic or with an unexplained cause. Stroke in multiple vascular territories MVT was present in 22/101 (22%) at baseline.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP86-ATMP86, February 1, 2024. Introduction:Tenecteplase improves reperfusion and functional outcomes in stroke patients with large vessel occlusion. Primary outcome was mRS at 90 days. Secondary outcomes were NIHSS at 24 hours and at discharge. versus 16.0, versus 7.0,
Stroke, Volume 55, Issue Suppl_1 , Page ATP180-ATP180, February 1, 2024. We assessed the clinical characteristics and outcomes in an international cohort of patients with COVID-CVST.Methods:This was a registry study of consecutive COVID-CVST patients diagnosed between March 2020 and March 2023.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionPatients with baseline disability account for one‐third of stroke presentations. However, there remains controversy in treatment selection for endovascular thrombectomy (EVT).
Stroke, Volume 55, Issue Suppl_1 , Page AWP2-AWP2, February 1, 2024. Background:Acute ischemic stroke is a leading cause of mortality and disability in the US, with 50% of patients with minor stroke symptoms (MSS). Large vessel occlusion (LVO) is found in 10% of MSS cases and predicts poor neurological outcomes.
By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable. since March 2017.He The financial impact of earlier, data-driven discharges is significant.
Stroke, Ahead of Print. BACKGROUND:Atrial fibrillation (AF) is a frequent underlying cause of cryptogenic stroke (CS) and its detection can be increased using implantable cardiac monitoring (ICM). Finally, stroke recurrence was documented in 5.6% Patients with CS with AF detection were older compared with the rest (P=0.045).
Stroke, Volume 55, Issue Suppl_1 , Page A137-A137, February 1, 2024. Introduction:Within 5 years of a stroke, approximately 25% of patients will have a recurrent event. Despite this benefit, 50% of patients with hypertension remain uncontrolled after a stroke. YNHHS has 5 hospitals and a large outpatient network.
Background This present study aimed to investigate the impact of left atrial appendage (LAA) isolation on adverse clinical outcomes, with a further stratified analysis by biatrial (BA) and left atrial lesion sets, in patients with atrial fibrillation (AF) undergoing surgical ablation (SA) concurrent with mitral valve (MV) surgery.
Receiving this CE mark certification for our Zio monitor and ZEUS system reflects our team’s commitment to delivering the highest quality services as we seek to drive better health outcomes and more equitable access for patients around the globe. milla1cf Wed, 01/03/2024 - 12:09 January 3, 2024 — iRhythm Technologies, Inc. ,
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content